"Designing Growth Strategies is in our DNA"

U.S. Transplantation Market Size, Share & COVID-19 Impact Analysis, By Product Type (Tissue Products, Immunosuppressive Drugs, and Preservation Solutions), By Application (Organ Transplantation and Tissue Transplantation), By End-user (Hospitals, Transplantation Centers, and Others), and Country Forecast, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI109170

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Number of Major Organ Transplantation, 2022
    2. Key Industry Developments- Mergers, Acquisitions and Partnerships
    3. Overview of Regulatory Scenario
    4. Key Industry Trends
    5. Impact of COVID-19 on the Transplantation Market
  5. U.S. Transplantation Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Tissue Products
      2. Immunosuppressive Drugs
      3. Preservation Solutions
    2. Market Analysis, Insights and Forecast – By Application
      1. Organ Transplantation
      2. Tissue Transplantation
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Transplantation Centers
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Arthrex, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Veloxis Pharmaceuticals, Inc. (Asahi Kasei Corporation)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. BioLife Solutions
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. TransMedics
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. F. Hoffmann-La Roche Ltd
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Zimmer Biomet
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Astellas Pharma Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Number of Major Organ Transplantation, 2022
    2. Key Industry Developments- Mergers, Acquisitions and Partnerships
    3. Overview of Regulatory Scenario
    4. Key Industry Trends
    5. Impact of COVID-19 on the Transplantation Market
  5. U.S. Transplantation Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Tissue Products
      2. Immunosuppressive Drugs
      3. Preservation Solutions
    2. Market Analysis, Insights and Forecast – By Application
      1. Organ Transplantation
      2. Tissue Transplantation
    3. Market Analysis, Insights and Forecast – By End User
      1. Hospitals
      2. Transplantation Centers
      3. Others
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Teva Pharmaceutical Industries Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Arthrex, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Veloxis Pharmaceuticals, Inc. (Asahi Kasei Corporation)
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. BioLife Solutions
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. TransMedics
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. F. Hoffmann-La Roche Ltd
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Zimmer Biomet
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Astellas Pharma Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
Read Less

Table 01: U.S. Transplantation Market Revenue (USD billion) Forecast, By Product Type, 2019–2030

Table 02: U.S. Transplantation Market Revenue (USD billion) Forecast, By Application, 2019–2030

Table 03: U.S. Transplantation Market Revenue (USD billion) Forecast, By End-user, 2019–2030

Figure 01: U.S. Transplantation Market Revenue Breakdown (USD billion, %) By Product Type, 2022 & 2030

Figure 02: U.S. Transplantation Market Value Share (%), By Product Type, 2022 & 2030

Figure 03: U.S. Transplantation Market Value Share (%), By Application, 2022 & 2030

Figure 04: U.S. Transplantation Market Value Share (%), By End-user, 2022 & 2030

Figure 05: U.S. Transplantation Market Share Analysis (%), By Company, 2022

U.S. Transplantation Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports